GSK, Others Appeal UK Watchdog's Pay-For-Delay Penalties

GlaxoSmithKline has appealed the U.K. Competition and Market Authority's decision to fine it £37.6 million ($54.2 million) for paying to postpone generic versions of the antidepressant Seroxat, while other companies have...

Already a subscriber? Click here to view full article